Alzheimer’s disease accounts for the majority of dementia cases (about 60–70%).
Alzheimer’s disease (AD) is the most common cause of dementia, responsible for about 60–70% of cases. It is a progressive neurodegenerative disorder that typically begins after age 65, though a smaller portion of cases can start earlier (early-onset). The earliest and most noticeable symptom is usually difficulty remembering recent events, and as the disease advances it can include language problems, disorientation (including getting lost), mood and behavioral changes, and increasing loss of independence. Pathologically, AD is characterized by the accumulation of abnormal protein deposits in the brain—amyloid plaques (amyloid beta) and neurofibrillary tangles (tau). These misfolded aggregates disrupt normal neuronal function and connections, leading to irreversible neuron degeneration over time. Diagnosis is based on clinical history and cognitive testing, with medical imaging and blood tests used to rule out other causes; definitive confirmation requires post-mortem examination of brain tissue. There is currently no known treatment that can stop or reverse AD progression, though some medications may temporarily improve symptoms. Worldwide, AD affects tens of millions of people, making it a major public health concern and a leading cause of death among dementias.
Alzheimer’s disease accounts for the majority of dementia cases (about 60–70%).
Early symptoms often involve short-term memory problems, with later progression to language, disorientation, behavioral changes, and loss of independence.
AD is driven by abnormal amyloid beta and tau protein accumulation, and diagnosis relies on clinical assessment supported by tests that exclude other causes.
A progressive neurodegenerative disorder and the most common cause of dementia, marked by memory and cognitive decline.
A syndrome of declining cognitive function that interferes with daily life, caused by various underlying diseases including Alzheimer’s.
Extracellular deposits of misfolded amyloid beta protein found in the brains of people with Alzheimer’s disease.
Intracellular aggregates of abnormal tau protein found in Alzheimer’s disease.
A clinical diagnosis of Alzheimer’s disease based on symptoms and cognitive testing, supported by tests that rule out other causes.
“Can you explain what "Alzheimer’s disease accounts for the majority of dementia cases (about 60–70%)." means in simple terms?”